Neuropeptide Y 2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats

British Journal of Pharmacology

Volumn 148, Issue 5, 2006, Pages 703-713

  Gradin, Kathryn A ^a   Buus, Carsten L ^b   Li, Jia Yi ^c   Frøbert, Ole ^b   Simonsen, Ulf ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

^c LUND UNIVERSITY   (Sweden)

Author keywords

BII0246TF; Hypertension; Mesenteric small arteries; Neuropeptide Y (NPY); Receptors; Spontaneously hypertensive rat; Wistar Kyoto rat

Indexed keywords

N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PANCREAS POLYPEPTIDE; PRAZOSIN; VASOPRESSIN; ARGININE; BENZAZEPINE DERIVATIVE; DRUG DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ESSENTIAL HYPERTENSION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; RECEPTOR BINDING; RESISTANCE BLOOD VESSEL; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION; WESTERN BLOTTING; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; HYPERTENSION; METABOLISM; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; VASODILATATION; WISTAR KYOTO RAT;

ANIMALS; ARGININE; BENZAZEPINES; BLOOD PRESSURE; BLOTTING, WESTERN; ELECTRIC STIMULATION; FEMALE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MESENTERIC ARTERIES; NEUROPEPTIDE Y; PERIPHERAL VASCULAR DISEASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, NEUROPEPTIDE Y; VASOCONSTRICTION; VASODILATION;

EID: 33745599141     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706774     Document Type: Article

References (36)

1. ABOUNADER, R., VILLEMURE, J.G. & HAMEL, E. (1995). Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226. Br. J. Pharmacol., 116, 2245-2250.
2. AGUIRRE, J.A., HEDLUND, P.B., NARVAEZ, J.A., BUNNEMANN, B., GANTEN, D. & FUXE, K. (1995). Increased vasopressor actions of intraventricular neuropeptide Y-(13-36) in spontaneously hypertensive versus normotensive Wistar-Kyoto rats - possible relationship to increases in Y-2 receptor-binding in the nucleus-tractus-solitarius. Brain Res, 684, 159-164.
3. CHU, D.Q., COX, H.M., COSTA, S.K.P., HERZOG, H. & BRAIN, S.D. (2003). The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y-1 and Y-2 receptors. Br. J. Pharmacol., 140, 422-430.
4. COELHO, E.F., FERRARI, M.F.R., MAXIMINO, J.R. & FIOR-CHADI, D.R. (2004). Change in the expression of NPY receptor subtypes Y1 and Y2 in central and peripheral neurons related to the control of blood pressure in rats following experimental hypertension. Neuropeptides, 38, 77-82.
5. DANIELS, A.J., GRIZZLE, M.K., WIARD, R.P., MATTHEWS, J.E. & HEYER, D. (2002). Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist. Regul. Pepl., 106, 47-54.
6. DOODS, H., GAIDA, W., WIELAND, H.A., DOLLINGER, H., SCHNORRENBERG, G., ESSER, F., ENGEL, W., EBERLEIN, W. & RUDOLF, K. (1999). BIIE0246: a selective and high affinity neuropeptide YY2 receptor antagonist. Eur. J. Pharmacol., 384, R3-R5.
7. DOODS, H.N., WIELAND, H.A., ENGEL, W., EBERLEIN, W., WILLIM, K.D., ENTZEROTH, M., WIENEN, W. & RUDOLF, K. (1996). BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul. Pept., 65, 71-77.
8. DUBINION, J.H., MI, Z., ZHU, C., GAO, L. & JACKSON, E.K. (2006). Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction. Hypertension, 47, 545-551.
9. FERES, T., BORGES, A.C.R., SILVA, E.G., PAIVA, A.C.M. & PAIVA, T.B. (1998). Impaired function of alpha-2 adrenoceptors in smooth muscle of mesenteric arteries from spontaneously hypertensive rats. Br. J. Pharmacol., 125, 1144-1149.
10. GEHLERT, D.R. (1998). Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc. Soc. Exp. Biol. Med., 218, 7-22.
11. GOUMAIN, M., VOISIN, T., LORINET, A.M., DUCROC, R., TSOCAS, A., ROZE, C., ROUET-BENZINEB, P., HERZOG, H., BALASUBRAMANIAM, A. & LABURTHE, M. (2001). The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y-2 receptor: pharmacological evidence and molecular cloning. Mol. Pharmacol., 60, 124-134.
12. GRADIN, K.A., LI, J.Y., ANDERSSON, O. & SIMONSEN, U. (2003). Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats. J. Vasc. Res., 40, 252-265.
13. JACKSON, D.N., MILNE, K.J., NOBLE, E.G. & SHOEMAKER, J.K. (2005). Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats. J. Physiol., 568, 573-581.
14. JIMENEZ-ALTAYO, F., GIRALDO, J., MCGRATH, J.C. & VILA, E. (2003). Enhanced noradrenergic transmission in the spontaneously hypertensive rat anococcygeus muscle. Br. J. Pharmacol., 140, 773-779.
15. KAWASAKI, H., SAITO, A. & TAKASAKI, K. (1990). Age-related decrease of calcitonin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat. Circ. Res., 67, 733-743.
16. LUFF, S.E., YOUNG, S.B. & MCLACHLAN, E.M. (2005). Hyperinnervation of mesenteric arteries in spontaneously hypertensive rats by sympathetic but not primary afferent axons - an ultrastructural analysis. J. Vasc. Res., 42, 348-358.
17. MALMSTROM, R.E. (1997). Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control. Acta Physiol. Scand. Suppl., 636, 1-55.
18. MALMSTROM, R.E. (2001). Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide YY2 receptor antagonist, in vivo. Br. J. Pharmacol., 133, 1073-1080.
19. MALMSTROM, R.E., LUNDBERG, J.O.N. & WEITZBERG, E. (2002). Autoinhibitory function of the sympathetic prejunctional neuropeptide YY2 receptor evidenced by BIIE0246. Eur. J. Pharmacol., 439, 113-119.
20. MANCIA, G., GRASSI, C., GIANNATTASIO, C. & SERAVALLE, G. (1999). Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension, 34, 724-728.
21. MCAULEY, M.A. & WESTFALL, T.C. (1992). Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. J. Pharmacol. Exp. Ther., 261, 863-868.
22. MICHEL, M.C., BECK-SICKINGER, A., COX, H., DOODS, H.N., HERZOG, H., LARHAMMAR, D., QUIRION, R., SCHWARTZ, T. & WESTFALL, T. (1998). XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.
23. NAVEILHAN, P., HASSANI, H., CANALS, J.M., EKSTRAND, A.J., LAREFALK, A., CHHAJLANI, V., ARENAS, E., GEDDA, K., SVENSSON, L., THOREN, P. & ERNFORS, P. (1999). Normal feeding behavior, body weight and leptin response require the neuropeptide YY2 receptor. Nat. Med., 5, 1188-1193.
24. NILSSON, T., YOU, J., SUN, X., HEDNER, T. & EDVINSSON, L. (1996). Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation. Blood Press., 5, 164-169.
25. NORMAN, R.A. & DZIELAK, D.J. (1986). Spontaneous hypertension is primarily the result of sympathetic overactivity and immunological dysfunction. Proc. Soc. Exp. Biol. Med., 182, 448-453.
26. PEDRAZZINI, T., SEYDOUX, J., KUNSTNER, P., AUBERT, J.F., GROUZMANN, E., BEERMANN, F. & BRUNNER, H.R. (1998). Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat. Med., 4, 722-726.
27. PRIETO, D., BUUS, C., MULVANY, M.J. & NILSSON, H. (1997). Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential. J. Physiol, 502 (Part 2), 281-292.
28. PRIETO, D., BUUS, C.L., MULVANY, M.J. & NILSSON, H. (2000). Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries. Br. J. Pharmacol., 129, 1689-1699.
29. PRIETO, D., GARCIA-SACRISTAN, A. & SIMONSEN, U. (1998). Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries. Regul. Pept., 75-76, 155-160.
30. PRIETO, D., LOS ARCOS, L.R., MARTINEZ, P., BENEDITO, S., GARCIA-SACRISTAN, A. & HERNANDEZ, M. (2004). Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries. Br. J. Pharmacol., 143, 976-986.
31. PRIETO, D., SIMONSEN, U. & NYBORG, N.C. (1995). Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries. Br. J. Pharmacol., 116, 2729-2737.
32. SMITH-WHITE, M.A., HARDY, T.A., BROCK, J.A. & POTTER, E.K. (2001). Effects of a selective neuropeptide YY2 receptor antagonist, BIIE0246, on Y-2 receptors at peripheral neuroeffector junctions. Br. J. Pharmacol., 132, 861-868.
33. TESSEL, R.E., MILLER, D.W., MISSE, G.A., DONG, X. & DOUGHTY, M.B. (1993). Characterization of vascular postsynaptic neuropeptide-Y receptor function and regulation.1. NPY-induced constriction in isolated rat femoral-artery rings is mediated by both Y1 and Y2 receptors - evidence from benextramine protection studies. J. Pharmacol Exp. Ther., 265, 172-177.
34. UDDMAN, R., MOLLER, S., NILSSON, T., NYSTROM, S., EKSTRAND, J. & EDVINSSON, L. (2002). Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues. Peptides, 23, 927-934.
35. YOU, J., EDVINSSON, L. & BRYAN JR, R.M. (2001). Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries. J. Cereb. Blood Flow Metab., 21, 77-84.
36. ZUKOWSKA-GROJEC, Z., KARWATOWSKA-PROKOPCZUK, E., ROSE, W., RONE, J., MOVAFAGH, S., JI, H., YEH, Y., CHEN, W.T., KLEINMAN, H.K., GROUZMANN, E. & GRANT, D.S. (1998). Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res., 83, 187-195.